Oxygenta Pharmaceutical Limited (BOM:524636)

Market Cap	2.09B -27.9%
Revenue (ttm)	1.13B +60.3%
Net Income	-174.51M
EPS	-4.74
Shares Out	36.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,860
Average Volume	6,711
Open	64.80
Previous Close	55.17
Day's Range	55.75 - 64.80
52-Week Range	45.30 - 133.50
Beta	0.52
RSI	59.97
Earnings Date	May 30, 2026

About Oxygenta Pharmaceutical

Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India. It offers active pharmaceuticals ingredients and commercial intermediates. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 175
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524636

Financial Performance

In fiscal year 2025, Oxygenta Pharmaceutical's revenue was 1.09 billion, an increase of 175.71% compared to the previous year's 396.42 million. Losses were -96.83 million, 178.3% more than in 2024.